home / stock / numif / numif news


NUMIF News and Press, Numinus Wellness Inc. From 05/30/24

Stock Information

Company Name: Numinus Wellness Inc.
Stock Symbol: NUMIF
Market: OTC
Website: numinus.ca

Menu

NUMIF NUMIF Quote NUMIF Short NUMIF News NUMIF Articles NUMIF Message Board
Get NUMIF Alerts

News, Short Squeeze, Breakout and More Instantly...

NUMIF - Numinus Wellness Charts Path To Profitability While Strengthening Community Ties

Vancouver, British Columbia--(Newsfile Corp. - May 30, 2024) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus'' or the "Company"), a leader in mental health care and in advancing evidence-based psychedelic-assisted therapies, announces a strategic blueprint aimed at fortif...

NUMIF - Numinus and Cybin Embark on a Groundbreaking Journey: Pioneering Phase 3 Trials for Major Depressive Disorder

Vancouver, British Columbia--(Newsfile Corp. - May 30, 2024) - In a significant stride towards transforming mental health care, Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23) has proudly announced that its research site, Cedar Clinical Research (CCR), has been selected for Cybin's P...

NUMIF - Numinus Wellness Receives Health Canada Approval for Study into Group Model for MDMA-Assisted Therapy

Numinus Wellness Receives Health Canada Approval for Study into Group Model for MDMA-Assisted Therapy Canada NewsWire VANCOUVER, BC , May 30, 2024 /CNW/ - Numinus Wellness Inc. (" Numinus " or the " Company ") (TSX: NUMI) (OTCQX: NUMIF), a mental heal...

NUMIF - Numinus Wellness Focused on Boosting Profitability and Expanding Community Support

Numinus Wellness Focused on Boosting Profitability and Expanding Community Support Canada NewsWire Numinus focuses resources on high-growth US operations, enhancing profitability Agreement with Field Trip Health to transition Canadian clinic operations, focusing on c...

NUMIF - Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003

Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003 Canada NewsWire VANCOUVER, BC , April 17, 2024 /CNW/ - Numinus Wellness Inc. (" Numinus " or the " Company ") (TSX: NUMI) (OTCQX: NUMIF), a mental health ca...

NUMIF - Numinus Wellness Inc. (NUMIF) Q2 2024 Earnings Call Transcript

2024-04-15 19:35:16 ET Numinus Wellness Inc. (NUMIF) Q2 2024 Earnings Call Transcript April 15, 2024 05:30 PM ET Company Participants Craig MacPhail - IR Payton Nyquvest - Founder & CEO Melony Valleau - Interim Chief Financial Officer Conference Call Pa...

NUMIF - Numinus Wellness reports Q2 results

2024-04-15 01:02:08 ET More on Numinus Wellness Seeking Alpha’s Quant Rating on Numinus Wellness Historical earnings data for Numinus Wellness Financial information for Numinus Wellness Read the full article on Seeking Alpha For further details...

NUMIF - Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results

Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results Canada NewsWire Q2 Fiscal 2024 Highlights Cash position of $6.6 million as of February 29, 2024 Gross profit of $0.5 million , a 22.7% decline over Q1 2024 Revenue of $5.0 million ...

NUMIF - Numinus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024

Numinus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024 Canada NewsWire VANCOUVER, BC , April 9, 2024 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and ...

NUMIF - PharmAla Biotech signs sale agreement with Numinus Wellness

2024-03-26 09:25:28 ET More on Pharmala Biotech Holdings Inc., Numinus Wellness, etc. Numinus Wellness Inc. (NUMIF) Q1 2024 Earnings Call Transcript Financial information for Pharmala Biotech Holdings Inc. Seeking Alpha’s Quant Rating on Numinus Wellness ...

Previous 10 Next 10